期刊文献+
共找到8篇文章
< 1 >
每页显示 20 50 100
大株红景天治疗冠心病心力衰竭的疗效观察 被引量:11
1
作者 詹秋璇 赵受伟 詹荷妹 《临床医学工程》 2017年第2期219-220,共2页
目的观察大株红景天注射液治疗冠心病心力衰竭的有效性及对心衰指标的影响。方法选择60例冠心病心力衰竭患者随机分为两组,对照组30例给予利尿、抗血小板、调脂、改善心室重构等常规抗心衰治疗,治疗组30例在常规治疗的基础上加用大株红... 目的观察大株红景天注射液治疗冠心病心力衰竭的有效性及对心衰指标的影响。方法选择60例冠心病心力衰竭患者随机分为两组,对照组30例给予利尿、抗血小板、调脂、改善心室重构等常规抗心衰治疗,治疗组30例在常规治疗的基础上加用大株红景天注射液静滴。两组均以10天为1个疗程。结果治疗后,治疗组的NT-pro BNP、6分钟步行试验结果均优于对照组(P<0.05)。结论大株红景天注射液是治疗冠心病心力衰竭的一种有效的中药制剂。 展开更多
关键词 大株红景天注射液 冠心病心力衰竭:疗效
在线阅读 下载PDF
银丹心泰滴丸治疗冠心病心绞痛疗效观察 被引量:2
2
作者 陈锐亮 林萍华 黄兰芳 《中国现代药物应用》 2011年第19期9-10,共2页
目的观察银丹心泰滴丸治疗冠心病心绞痛的疗效。方法将76例患者随机分为两组,对照组采用常规抗心绞痛治疗包括硝酸酯类,钙拮抗剂,β-受体阻滞剂等治疗,治疗组在对照组的基础上加用银丹心泰滴丸口服,两组疗程均为8周,观察两组治疗前后心... 目的观察银丹心泰滴丸治疗冠心病心绞痛的疗效。方法将76例患者随机分为两组,对照组采用常规抗心绞痛治疗包括硝酸酯类,钙拮抗剂,β-受体阻滞剂等治疗,治疗组在对照组的基础上加用银丹心泰滴丸口服,两组疗程均为8周,观察两组治疗前后心绞痛症状、心电图及血脂变化情况。结果治疗后,心绞痛疗效有效率治疗组84.21%,对照组63.16%;心电图疗效有效率治疗组81.58%,对照组60.53%;血脂变化治疗组有明显改善,对照组无明显改善,两组差异有统计学意义(P值<0.05)。结论银丹心泰滴丸可明显改善心肌缺血情况,缓解心绞痛症状,降低胆固醇和甘油三酯,提高患者的生活质量。 展开更多
关键词 银丹心泰滴丸:冠心病:心绞痛:疗效
在线阅读 下载PDF
血府逐淤汤加味治疗冠心病心肌缺血65例疗效观察 被引量:2
3
作者 柳素珍 《医学理论与实践》 2013年第10期1305-1306,共2页
目的:探讨血府逐淤汤加味治疗冠心病心肌缺血的临床疗效。方法:选择自2010年1月-2012年7月我院中医内科收治的冠心病心肌缺血患者130例,随机分为观察组与对照组,各65例。两组130例均常规运用西药对症治疗,观察组加用采用血府逐淤汤加味... 目的:探讨血府逐淤汤加味治疗冠心病心肌缺血的临床疗效。方法:选择自2010年1月-2012年7月我院中医内科收治的冠心病心肌缺血患者130例,随机分为观察组与对照组,各65例。两组130例均常规运用西药对症治疗,观察组加用采用血府逐淤汤加味治疗冠心病、心绞痛、心肌缺血等淤血内阻证患者,2周1个疗程后观察所有患者治疗前、后心绞痛、血脂、血流变及心电图改善情况。结果:通过对65例冠心病心肌缺血患者采用血府逐淤汤加味治疗1个疗程之后,其中痊愈53例,显效3例,有效4例,无效5例,总有效率为92.31%;对照组治愈41例,好转9例,有效5例,无效10例,总有效率为84.62%,两组比较差异有显著性(P<0.05)。结论:血府逐淤汤加味治疗冠心病心肌缺血临床疗效满意,能有效改善微循环、特别是改善心肌供血疗效显著,从而心电图明显改善,无不良反应。 展开更多
关键词 血府逐淤汤加味冠心病心肌缺血疗效观察
在线阅读 下载PDF
自拟导痰祛瘀汤治疗糖尿病合并冠心病68例效果观察 被引量:7
4
作者 刘国强 《中国社区医师(医学专业)》 2012年第23期167-167,共1页
目的:观察自拟导痰祛瘀汤治疗糖尿病合并冠心病的临床疗效。方法:收治糖尿病合并冠心病患者130例,随机分为观察组(自拟导痰祛瘀汤治疗组)68例和对照组(曲美他嗪治疗组)62例,连续治疗4周后,比较两组的治疗效果及不良反应情况。结果:观察... 目的:观察自拟导痰祛瘀汤治疗糖尿病合并冠心病的临床疗效。方法:收治糖尿病合并冠心病患者130例,随机分为观察组(自拟导痰祛瘀汤治疗组)68例和对照组(曲美他嗪治疗组)62例,连续治疗4周后,比较两组的治疗效果及不良反应情况。结果:观察组治疗后总有效率为95.6%,明显优于对照组(88.7%)。观察组在进行治疗中未发现明显不良反应,而对照组在进行治疗中出现头晕1例,经调整用药后好转。结论:自拟导痰祛瘀汤加减治疗糖尿病合并冠心病效果理想,且临床用药安全。 展开更多
关键词 导痰祛瘀汤 糖尿病 冠心病疗效 中医
在线阅读 下载PDF
他汀类联合心血管药物治疗冠心病的临床疗效及不良反应研究
5
作者 陈月朗 《中文科技期刊数据库(全文版)医药卫生》 2023年第8期69-71,共3页
研究分析他汀类药物结合心血管药物在冠心病患者临床治疗中表现出的治疗效果及不良反应。方法2021年3月入院到2022年3月出院的患者人数为120,针对上述样本展开深入研究分析,对其应用随机数字法分类为对照组及观察组,每组平均分配样本60... 研究分析他汀类药物结合心血管药物在冠心病患者临床治疗中表现出的治疗效果及不良反应。方法2021年3月入院到2022年3月出院的患者人数为120,针对上述样本展开深入研究分析,对其应用随机数字法分类为对照组及观察组,每组平均分配样本60。临床治疗中,为对照组60例样本数据提供常规的心血管药物治疗干预,为观察组60例样本数据提供对照组治疗基础上的他汀类药物联合作用,患者需接受治疗总有效率与不良反应发生率的对比研究。结果 显效及有效总和更高的人数为观察组,P<0.05;低密度脂蛋白胆固醇与血流变学指标更高的小组为对照组,P<0.05;观察组高密度脂蛋白胆固醇水平更高,P<0.05;对照组面临着更高的不良反应风险,P<0.05。结论 常规心血管药物联合他汀类药物作用在冠心病的临床治疗中,能够实现临床护理总有效率的提升,控制血脂的同时也明显减轻了临床症状,数据显示完全可以临床推广使用。 展开更多
关键词 他汀类药物 心血管药物冠心病临床疗效不良反应
在线阅读 下载PDF
Firebird stent for the treatment of patients with coronary heart disease: short-term clinical outcome 被引量:1
6
作者 Hai-Ying Wang Jin-Bo Wang +6 位作者 Feng Liang Da-Yi HU Ming-Ying Wu Tian-Chang Li Chu-Zhong Tang Ji-Yun Wang Chang-Lin Lu 《Journal of Geriatric Cardiology》 SCIE CAS CSCD 2009年第3期157-161,共5页
Objective The sirolimus-eluting stent (SES) has dramatically reduced the rate ofrestenosis in comparison to that with the baremetal stent (BMS).This study aimed to evaluate the short-term efficacy and safety of Fi... Objective The sirolimus-eluting stent (SES) has dramatically reduced the rate ofrestenosis in comparison to that with the baremetal stent (BMS).This study aimed to evaluate the short-term efficacy and safety of Firebird stent implantation for patients with coronary heart disease (CHD). Methods From Apri12006 through July 2007, 155 patients (mean age 58.93±10.27 years ) with CHD were implanted with Firebird stent or Cypher select stent at Daxing Hospital. Patients were followed up for one year. All-cause mortality, major adverse cardiac events (MACE, including cardiac death, myocardial infarction, recurrence of angina pectoris, heart failure, revascularization, and adverse arrhythmia) and stent thrombosis were compared between the 2 groups. Results Of the 155 consecutive patients, 147 patients were revascularized completely. Of these patients, 48 (with 59 lesions) were treated with Firebird stent, 59 patients (with 75 lesions) with Cypher select stent. The demographic characteristics were similar in the 2 groups. All the angiographic and procedural results were not significantly different between the 2 groups. All-cause mortality, myocardial infarction, recurrence of angina pectoris, MACE and stent thrombosis were almost identical between the 2 groups before discharge, at 6 months and at one year .Conclusion The short-term efficacy and safety of Firebird stent are similar to that of the cypher select stent for the treatment of patients with CHD (J Geriatr Cardlo12009; 6:157-161). 展开更多
关键词 coronary heart disease sirolimus-eluting stent percutaneous coronary intervention
在线阅读 下载PDF
Stent supported coronary angioplasty in patients with severe ventricular dysfunction 被引量:2
7
作者 李成祥 贾国良 +1 位作者 郭文怡 李伟杰 《Chinese Medical Journal》 SCIE CAS CSCD 2002年第3期355-358,共4页
OBJECTIVE: To assess the immediate- and long-term outcomes of stent supported coronary angioplasty in patients with severe left ventricular dysfunction. METHODS: Seventy-four consecutive patients with angiographic lef... OBJECTIVE: To assess the immediate- and long-term outcomes of stent supported coronary angioplasty in patients with severe left ventricular dysfunction. METHODS: Seventy-four consecutive patients with angiographic left ventricular ejection fractions or = 1 was seen in 29 (73%) of 40 successfully treated congestive heart failure patients at 6 months after the procedure. During long-term follow-up, 58 (87.9%) of 66 patients with clinical success were alive, including 44 (68.6%) free from cardiac events. CONCLUSIONS: Patients with severe left ventricular dysfunction treated with stent supported PTCA experience a high rate of success, low procedure related mortality and satisfactory long-term survival. 展开更多
关键词 STENTS ADULT Aged Angioplasty Transluminal Percutaneous Coronary Female Follow-Up Studies Humans Male Middle Aged Ventricular Dysfunction Left
原文传递
Therapeutic effect in patients with coronary heart disease based on information analysis from Traditional Chinese Medicine four diagnostic methods 被引量:13
8
作者 Yiqin Wang Jin Xu +8 位作者 Rui Guo Chaoxia Xu Yiming Hao Chunfeng Chen Yijian Hong Xiangqun Xiao Wenjie Xu Jing Hong Zhao Lei 《Journal of Traditional Chinese Medicine》 SCIE CAS CSCD 2014年第1期34-41,共8页
OBJECTIVE:To study information gained by Traditional Chinese Medicine(TCM)four diagnostic methods and characteristics of syndrome development before and after treatment in patients with coronary heart disease,and to p... OBJECTIVE:To study information gained by Traditional Chinese Medicine(TCM)four diagnostic methods and characteristics of syndrome development before and after treatment in patients with coronary heart disease,and to probe into assessment indexes of therapeutic effects with distinctive TCM features.METHODS:Information from the four diagnostic methods before and after treatment in 100 patients with coronary heart disease was collected using the TCM interrogation scale,a pulse condition instrument,a tongue-face diagnosis instrument,anda voice diagnosis information collection system.Changes in the four diagnostic method results from before and after treatment were analyzed with frequency analysis and t-test methods.RESULTS:Before treatment,deficiency syndrome complicated with hyperactivity of pathogenic factors was most common.After treatment,deficiency syndrome was most common.This change from complex syndromes to single syndromes indicates disease and syndrome alleviation.Frequencies of symptoms gained by interrogation after treatment for syndrome of deficiency of heart-Qi,syndrome of deficiency of heart-Yin,and turbid phlegm syndrome were all less severe than those before treatment.Parameters of face color,color on all sub-regions of tongue,color of tongue fur,septic and greasy fur,and lip color after treatment all had significant changes.After treatment,part of the voice diagnosis parameters in the deficiency of heart-Yin and turbid phlegm syndromes had significant changes,but no significant changes were found in the deficiency of heart-Qi syndrome.CONCLUSION:Use of the TCM four diagnostic methods can provide an effective basis forTCM syndrome diagnosis,observation of development of state of illness,and evaluation of clinical therapeutic effects. 展开更多
关键词 MEDICINE Chinese traditional Four di-agnostic methods SYNDROME Treatment outcome Coronary disease
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部